ProQR Therapeutics N.V. Stock
ProQR Therapeutics N.V. Stock
A loss of -2.400% shows a downward development for ProQR Therapeutics N.V..
ProQR Therapeutics N.V. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 3 € there is potential for a 105.34% increase which would mean more than doubling the current price of 1.46 € for ProQR Therapeutics N.V..
Our community identified positive and negative aspects for ProQR Therapeutics N.V. stock for the coming years. 7 users see the criterium "Worthwhile Investment for the next years" as a plus for the ProQR Therapeutics N.V. stock. On the other hand our users think that "Company culture" could be a problem in the future.
Pros and Cons of ProQR Therapeutics N.V. in the next few years
Pros
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ProQR Therapeutics N.V. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ProQR Therapeutics N.V. | -2.400% | -0.532% | -2.412% | -13.468% | -10.946% | 13.238% | -65.186% |
| Pharming Group | 1.310% | -21.323% | -27.590% | -6.141% | -39.244% | -22.413% | -8.841% |
| Heron Therapeutics Inc. | 0.230% | 2.964% | 15.931% | -70.432% | -61.329% | -70.694% | -95.846% |
| Formycon AG | 1.790% | 1.174% | -1.660% | -28.856% | -25.793% | -71.617% | -66.383% |
Comments
ProQR Therapeutics (PRQR) had its price target lowered by JonesTrading from $11.00 to $10.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRQR provided by MarketBeat
ProQR Therapeutics (PRQR) had its "buy" rating reaffirmed by Chardan Capital. They now have a $4.00 price target on the stock.
Show more
Ratings data for PRQR provided by MarketBeat
ProQR Therapeutics (PRQR) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $9.00 price target on the stock.
Show more
Ratings data for PRQR provided by MarketBeat